Search hospitals > Arizona > Tucson
University of Arizona
Claim this profileTucson, Arizona 85724
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Lymphoma
Conducts research for Recurrence
Conducts research for Lung Cancer
413 reported clinical trials
62 medical researchers
Summary
University of Arizona is a medical facility located in Tucson, Arizona. This center is recognized for care of Cancer, Tumors, Lymphoma, Recurrence, Lung Cancer and other specialties. University of Arizona is involved with conducting 413 clinical trials across 1,010 conditions. There are 62 research doctors associated with this hospital, such as Holly E. Pariury, Rachna Shroff, M.D., Pavani Chalasani, and Aaron Scott, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Tumors
Global LeaderStage IV
Stage I
Stage III
Top PIs
Holly E. PariuryBanner University Medical Center - Tucson7 years of reported clinical research
Expert in Tumors
Expert in Lymphoma
31 reported clinical trials
69 drugs studied
Rachna Shroff, M.D.University of Arizona Cancer Center4 years of reported clinical research
Studies Cancer
Studies Pancreatic Cancer
14 reported clinical trials
33 drugs studied
Pavani ChalasaniUniversity of Arizona Cancer Center6 years of reported clinical research
Expert in Breast Cancer
Studies Peripheral Neuropathy
15 reported clinical trials
31 drugs studied
Aaron Scott, MDUniversity of Arizona Cancer Center7 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
11 reported clinical trials
24 drugs studied
Clinical Trials running at University of Arizona
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Language Disorder
Multiple Myeloma
Tumors
Ovarian Tumors
Specific Language Impairment
Pancreatic Cancer
Smoking Cessation
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Arizona?
University of Arizona is a medical facility located in Tucson, Arizona. This center is recognized for care of Cancer, Tumors, Lymphoma, Recurrence, Lung Cancer and other specialties. University of Arizona is involved with conducting 413 clinical trials across 1,010 conditions. There are 62 research doctors associated with this hospital, such as Holly E. Pariury, Rachna Shroff, M.D., Pavani Chalasani, and Aaron Scott, MD.
Where is University of Arizona located?
**University of Arizona Hospital - Tucson Location**
- Address: 1625 N Campbell Ave, Tucson, AZ 85719.
- For parking, use the UA Parking Garage located at 1501 N. Campbell Ave. From there, proceed to the College of Medicine building's sixth floor.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Arizona, reach out to the Office of Scholarships & Financial Aid at (520) 621-1858 or through their online contact form. For billing and financial assistance at Banner Health, including Banner hospitals, contact (888) 264-2127.
What insurance does University of Arizona accept?
The University of Arizona offers the United Healthcare Student Resources insurance plan, catering to undergraduate, graduate, international students, post-doctoral fellows, J1 Visiting Scholars, and J1 Student Interns. This comprehensive plan is designed for those needing an affordable alternative or an Arizona provider network, ensuring inclusivity across various student demographics. Primary care must be received through ASU Health Services, with the plan's terms annually negotiated by a Tri-University leadership group and student advisory committees.
What awards or recognition has University of Arizona received?
The University of Arizona Hospital in Tucson, Arizona, is an IBM Watson Health 100 Top Hospital and an accredited Cardiac Receiving Center by the Arizona Department of Health Services (ADHS). It is part of the University of Arizona's research enterprise, with over $955M in annual research expenditures. The hospital supports researchers with resources, training, and specialized facilities.